Atlas Trials

A Phase 2 Study of a Subcutaneous Injection of TAK-850 in Healthy Adult Participants

Clinical trial NCT02713061 · WITHDRAWN

Trial details

NCT number
NCT02713061
Sponsor
Takeda
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Influenza Prevention
Start date
2016-03-01
Primary completion
2016-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.